跳至主要内容
临床试验/NCT01902667
NCT01902667已完成不适用

Preoperative Imaging in Retroperitoneal Sarcoma

Institute of Cancer Research, United Kingdom1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
Prediction, by MRI, of early response to radiotherapy prior to tumour shrinkage

研究概览

简要总结

This is a prospective observational study in which patients with untreated retroperitoneal sarcoma will have Magnetic Resonance Imaging (MRI) prior to surgery. In addition, patients who will be undergoing pre-operative radiotherapy will have an additional MRI scan at two weeks post radiotherapy. For both groups, the magnetic resonance images will be correlated with tumour pathology.

The study hypothesis is that Magnetic Resonance Imaging will provide a more accurate assessment of tumour volume and local staging than CT and will identify areas of altered oxygenation, cellularity and perfusion which change in response to radiotherapy before tumour shrinkage occurs.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with retroperitoneal sarcomas planned for surgical resection +/- preoperative radiotherapy.

排除标准

  • MRI incompatible metal implants
  • claustrophobia

结局指标

主要结局

Prediction, by MRI, of early response to radiotherapy prior to tumour shrinkage

时间窗: 2-4 weeks

Changes in volume, maximum axial diameter, ADC, F, D, D\*, T2, R2\* and enhancing fraction from baseline to post radiotherapy will be presented. A paired T-test (or Wilcoxon Signed Rank Test) may be used to test the difference between baseline and post radiotherapy. Differences in these values will be presented for responders and non-responders, which will be tested by independent T-test. Response will be determined by tumour size, enhancing fraction and histopathological evidence of response.

次要结局

  • To determine the reproducibility of multi-parametric MRI measurements within tumour regions of interest in patients with retroperitoneal sarcoma.(1-7 days)

研究者

发起方
Institute of Cancer Research, United Kingdom
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nandita deSouza

Professor of Translational Imaging

Institute of Cancer Research, United Kingdom

研究点 (1)

Loading locations...

相似试验